Not Tagged
Not Tagged
['bcsm', 'mbc']
dr. is touching on genomic profiling for mbc #bcsm. timing indeed matters (sample from primary tumor vs from a later metastatic). tissue vs ctdna each has pros and cons. ctdna easier to obtain esp. for longitudinal data but more false negative #asco22
Medical oncologist - Developmental Therapeutics - NIH/NCI - opinions my own - retweet is not endorsement